Cold chain is a temperature-controlled supply chain that involves the movement and storage of goods under temperature-regulated conditions from manufacturers to customers. It includes cold storage and cold transport facilities for temperature-sensitive medicines such as vaccines, biologics, and pharmaceutical drugs. There are various advantages of cold chain logistics such as preventing degradation, maintaining effectiveness, and extending shelf life of these medicines. As the demand for biologics and cell and gene therapies continues to grow, cold chain logistics have become increasingly essential to safely transport and store these highly fragile and temperature-sensitive medicines.

The global Cold Chain Market is estimated to be valued at US$ 270.08 Mn in 2023 and is expected to exhibit a CAGR of 7.3%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The growing demand for temperature-sensitive medicines, especially biologics, offers significant market opportunity for cold chain logistics. Biologics require complex cold chain management due to their fragile nature and narrow ideal storage temperature ranges. Their global sales reached over US$ 250 billion in 2019 and are expected to grow at a double-digit rate in the coming years. As biologic approvals and launches continue to increase, cold chain logistics providers can capitalize on this opportunity by offering end-to-end temperature-controlled packaging, storage and transportation solutions tailored for biologics. Standardizing processes, improving quality control and utilizing digital technologies for real-time monitoring will allow effective and reliable management of biologics cold chain. This can help enhance product quality, patient outcomes and tap into the exponential growth of this therapeutics segment.

Porter's Analysis
Threat of new entrants: The cold chain market requires significant capital investment which creates barriers for new companies. New entrants also need to gain customer trust for temperature controlled logistics.

Bargaining power of buyers: The global demand for temperature sensitive products is large and growing which gives buyers more bargaining power to negotiate on pricing and quality standards.

Bargaining power of suppliers: Major players dominate the supply chain with integrated operations across cold storage, transportation and logistics. This allows suppliers to exercise some control over pricing.

Threat of new substitutes: No viable alternatives exist currently for maintaining product quality during storage and transport that requires controlled temperatures.

Competitive rivalry: Large global players compete intensely on technology, infrastructure and service quality leading to pricing pressures.

SWOT Analysis
Strength: Established infrastructure, technology leadership and compliance with global quality standards provide an advantage.

Weakness: Downtime during power or equipment failure risks damage to perishable goods. Rural supply chains need more investment.

Opportunity: Growth in biopharma, food processing, e-commerce sectors driving opportunities. Asia Pacific markets will grow rapidly.

Threats: Disruptions from extreme weather or public health crises impact operations and demand. Rising energy costs squeeze margins.

Key Takeaways
The global  Cold Chain Market Share is expected to witness high growth driven by expanding industries that rely on temperature-controlled logistics. The market size is projected to reach US$ 270.08 million by 2024, registering a CAGR of 7.3%  during the forecast period.

Regional analysis: Asia Pacific dominates currently due to a large consumer base and fast growing pharmaceutical sector in countries like China, India and Japan. China has emerged as a major exporter of vaccines, biologics and season products requiring cold chain infrastructure.

Key players analysis: Key players operating in the cold chain market are Novo Nordisk A/S, Pfizer, Inc., Eli Lilly and Company, Changchun GeneScience Pharmaceutical Co., Ltd., Sandoz International GmbH, Ipsen Pharma, LG Chem, Merck KGaA, Genentech, Inc., Ferring B.V., AnkeBio Co., Ltd, Reliance Life Sciences, JCR Pharmaceuticals Co., Ltd, Zhongshan Sinobioway Hygene Biomedicine Co., Ltd and USV Private Limited. These companies have integrated their offerings across temperature monitoring, transportation and warehouse logistics to serve industries globally.
 
Check below related articles on this topic: https://www.pressreleasebulletin.com/the-growing-cold-chain-market-demand-analysis/
https://shoutingstars.com/automotive-embedded-systems-future-of-in-vehicle-technology
​